BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6947720)

  • 1. Characteristics of two anti-tumour monoclonal antibody preparations.
    Price MR; Dennick RG; Fang CY; Hannant D; Embleton MJ; Gunn B; Baldwin RW
    Arch Geschwulstforsch; 1981; 51(4):302-9. PubMed ID: 6947720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against osteosarcoma and colon cancer.
    Embleton MJ; Brown A; Gunn B; Byers VS; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):35-8. PubMed ID: 6591916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
    Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
    Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
    Price MR; Pimm MV; Baldwin RW
    Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigens on naturally occurring animal and human tumors detected by monoclonal antibodies.
    Embleton MJ; Gunn B; Byers VS; Baldwin RW
    Transplant Proc; 1981 Dec; 13(4):1966-9. PubMed ID: 6949387
    [No Abstract]   [Full Text] [Related]  

  • 7. The production and preclinical characterization of a chimeric anti-breast-cancer antibody, cBC2.
    Sutton VR; Burgess J; Pietersz GA; Li WJ; McKenzie IF; Trapani JA
    Ther Immunol; 1994 Apr; 1(2):83-93. PubMed ID: 7584487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma patients: isolation of serum antibodies by affinity chromatography.
    Tsang KY; Fudenberg HH; Gnagy MJ
    J Natl Cancer Inst; 1981 Dec; 67(6):1183-9. PubMed ID: 6796743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant mouse/human chimeric anti-colorectal carcinoma antibody cACT19.
    Xiang J; Moyana T; Liu E
    Hum Antibodies Hybridomas; 1994; 5(3-4):105-15. PubMed ID: 7756575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibody developed against a metastasizing paraganglioma: preparation and preclinical studies.
    Freiberg B; Puhlmann CM; Anderer FA
    Anticancer Res; 1995; 15(6B):2489-93. PubMed ID: 8669812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMMR-2, a monoclonal antibody to human osteosarcoma.
    McGuire MH; Ritter RA; Roodman ST; Tsai CC
    Chir Organi Mov; 1990; 75(1 Suppl):5. PubMed ID: 2249557
    [No Abstract]   [Full Text] [Related]  

  • 12. Computer-aided hybridoma screening. Production of monoclonal antibodies against membrane fractions from mammary tumour tissue.
    Heinsohn R; Poschmann A
    J Immunol Methods; 1987 Feb; 96(2):179-84. PubMed ID: 3805738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibodies utilizing the host anti-idiotypic network.
    Hatzistilianou MN; Sivolapenko GB; Courtenay-Luck NS; Epenetos AA; Ritter MA
    In Vivo; 1995; 9(2):139-44. PubMed ID: 7548789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monoclonal antibodies produced in transgenic BABkappa,lambda mice recognising idiotypic immunoglobulins of human lymphoma cells.
    Suárez E; Yáñez R; Barrios Y; Díaz-Espada F
    Mol Immunol; 2004 Jul; 41(5):519-26. PubMed ID: 15183930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies (IgM) against a murine carcinoma, Lewis lung carcinoma (3LL): production, purification and in vitro selectivity.
    Midoux P; Roche AC; Monsigny M
    Immunol Lett; 1984; 8(3):131-6. PubMed ID: 6500631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to rat sarcomata. II. A syngeneic IgG2b antibody with anti-tumour activity.
    North SM; Dean CJ
    Immunology; 1983 Aug; 49(4):667-71. PubMed ID: 6874004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 18. Basic approach to application of chemoimmunoliposomes for cancer therapy.
    Hashimoto Y; Sugawara M; Kamiya T; Suzuki S; Tanaka T; Hojo H
    NCI Monogr; 1987; (3):89-94. PubMed ID: 3821923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal anti-MM46 antibody:ricin A chain conjugate: in vitro and in vivo antitumor activity.
    Seto M; Umemoto N; Saito M; Masuho Y; Hara T; Takahashi T
    Cancer Res; 1982 Dec; 42(12):5209-15. PubMed ID: 6814753
    [No Abstract]   [Full Text] [Related]  

  • 20. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
    Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.